Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$209K Buy
14,200
+3,900
+38% +$39.8K ﹤0.01% 4878
2025
Q2
$102K Buy
+10,300
New +$85.3K ﹤0.01% 4162
2025
Q1
Sell
-10,700
Closed -$83.4K 5040
2024
Q4
$83.4K Buy
+10,700
New +$88.1K ﹤0.01% 4855
2023
Q4
Sell
-10,600
Closed -$164K 4674
2023
Q3
$164K Buy
+10,600
New +$178K ﹤0.01% 3831
2023
Q2
Sell
-10,200
Closed -$152K 4423
2023
Q1
$152K Buy
+10,200
New +$133K ﹤0.01% 3536

Other funds holding ETNB

Wolverine Trading's ETNB Position: Q1 2025 in Review

Wolverine Trading sold out of 89bio (ETNB) in Q1 2025, closing a stake of 12,354 shares — an estimated $96.2K sold.

Wolverine Trading first reported a position in ETNB in Q4 2024 and held it in 1 quarter. The position peaked at $96.2K in Q4 2024. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

  • Wolverine Trading reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 12,354 89bio shares in Q1 2025, an estimated $96.2K.
  • Wolverine Trading first reported a position in 89bio in Q4 2024 and held it in 1 quarter.
  • Wolverine Trading's 89bio position peaked at $96.2K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.